Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
Health Care · Health Care Equipment & Supplies · US
$91.53
+2.68% today · -8.5% 1Y
Zimmer Biomet Holdings, Inc. (NYSE: ZBH) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $17.00B and employs 17,000 people.
Over the last twelve months the share price has lost 8.5%, trading between 79.12 and 106.88.
Tweenvest scores Zimmer Biomet Holdings, Inc. across four factors: quality 78/100, value 78/100, growth 46/100, dividend 33/100. Its strongest factor is quality.
ZBH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $17.00B
- Revenue (TTM)
- $8.51B
- P/E
- 21.66
- EPS
- 4.12
- Dividend yield
- 1.08%
- Beta (5Y)
- 0.49
- 52-week high
- $106.88
- 52-week low
- $79.12
- Avg volume (3M)
- —
- Shares outstanding
- 190.74M
- Employees
- 17,000
- Next earnings
- —
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
- ISIN
- US98956P1021
- Founded
- 1927
- Listed since
- Jul 25, 2001
- Exchange
- New York Stock Exchange
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Terumo CorporationTSE: 4543 | $21.28B | ¥2,284.00 | -1.06% |
| STERIS plcNYSE: STE | $20.90B | $220.46 | +2.83% |
| Sonova Holding AGSWX: SOON | $18.92B | CHF267.80 | +1.21% |
| Straumann Holding AGSWX: STMN | $17.24B | CHF91.64 | +2.00% |
| Fisher & Paykel Healthcare Corporation LimitedNZSE: FPH | $15.72B | NZ$47.70 | +0.61% |
| Solventum CorporationNYSE: SOLV | $14.86B | $86.08 | -1.39% |
| Coloplast A/SCPSE: COLO B | $14.70B | Dkr446.30 | +2.39% |
| Olympus CorporationTSE: 7733 | $13.42B | ¥2,000.00 | +0.50% |
Figures last refreshed Oct 11, 2026.